Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06551584 · ClinicalTrials.gov registry record · Phase 1

Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

A Phase 1 study of Acute Myeloid Leukemia and Myelodysplastic Syndromes, sponsored by Stanford University.

Recruiting
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT06551584 is a Phase 1 study of Acute Myeloid Leukemia and Myelodysplastic Syndromes that is actively recruiting participants, run by Stanford University. The registered enrollment target is 24 participants, below the 116-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06551584, a Phase 1 study of Acute Myeloid Leukemia and Myelodysplastic Syndromes, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The study goal is to characterize the safety of the combination of Orca-T with dual agent GVHD prophylaxis.

Conditions Studied

Acute Myeloid Leukemia Myelodysplastic Syndromes Mixed Phenotype Acute Leukemia Acute Lymphoid Leukemia

Interventions

  • DRUG ORCA-T

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-12-01
Est. Completion 2026-12
Phase Phase 1

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06551584

The ClinicalTrials.gov registry entry for NCT06551584 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (79% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 1 intervention - of which ORCA-T is the first listed.

NCT06551584 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06551584 about?

NCT06551584 is a clinical study titled "Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT". The study goal is to characterize the safety of the combination of Orca-T with dual agent GVHD prophylaxis.

What is the current status of trial NCT06551584?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2025-12-01. Estimated completion is 2026-12.

What conditions does trial NCT06551584 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia, Acute Lymphoid Leukemia.

What interventions are being tested in trial NCT06551584?

The interventions under investigation include: ORCA-T (DRUG).

Who is sponsoring clinical trial NCT06551584?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06551584 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Myeloid Leukemia

All registered trials for this condition

Myelodysplastic Syndromes

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.